Cruz-Bermúdez et al. reported that SCLC cells, with increased PGC-1a, induced by ZLN005 treatment, showed reduced cisplatin-driven apoptosis, whereas PGC-1α interference increased cisplatin sensitivity [130]. Here, PPARGC1A is linked to small cell lung carcinoma.